Zhejiang Medicine Co., Ltd. (600216.SS)
CNY 13.61
(0.74%)
CNY 13.61
(0.74%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.13 Billion CNY | -33.88% |
| 2022 | 1.21 Billion CNY | -27.46% |
| 2021 | 1.78 Billion CNY | 25.05% |
| 2020 | 1.4 Billion CNY | 56.11% |
| 2019 | 913.48 Million CNY | -6.71% |
| 2018 | 895.02 Million CNY | 34.89% |
| 2017 | 695.97 Million CNY | -28.9% |
| 2016 | 897.42 Million CNY | 68.89% |
| 2015 | 511.07 Million CNY | 9.72% |
| 2014 | 479.89 Million CNY | -26.29% |
| 2013 | 705.79 Million CNY | -33.74% |
| 2012 | 1.15 Billion CNY | -14.17% |
| 2011 | 1.33 Billion CNY | -8.43% |
| 2010 | 1.51 Billion CNY | -11.09% |
| 2009 | 1.63 Billion CNY | 15.13% |
| 2008 | 1.43 Billion CNY | 391.35% |
| 2007 | 276.54 Million CNY | 17.3% |
| 2006 | 257.56 Million CNY | 13.17% |
| 2005 | 227.57 Million CNY | 74.46% |
| 2004 | 130.44 Million CNY | 13.51% |
| 2003 | 114.92 Million CNY | -5.34% |
| 2002 | 121.4 Million CNY | 17.99% |
| 2001 | 102.89 Million CNY | -11.23% |
| 2000 | 100.7 Million CNY | -16.47% |
| 1999 | 129.22 Million CNY | 1.2% |
| 1998 | 137.11 Million CNY | 53.81% |
| 1997 | 89.14 Million CNY | 50.91% |
| 1996 | 59.06 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 143.8 Million CNY | -0.31% |
| 2024 Q3 | 602.69 Million CNY | 39.58% |
| 2024 Q2 | 406.33 Million CNY | 49.21% |
| 2023 Q2 | 171.29 Million CNY | 42.12% |
| 2023 Q3 | 50.43 Million CNY | -70.56% |
| 2023 Q4 | -161.69 Million CNY | -420.63% |
| 2023 FY | - CNY | -33.88% |
| 2023 Q1 | 120.52 Million CNY | 585.79% |
| 2022 FY | - CNY | -27.46% |
| 2022 Q1 | 329.72 Million CNY | -5.67% |
| 2022 Q2 | 233.16 Million CNY | -29.28% |
| 2022 Q3 | 149.73 Million CNY | -35.78% |
| 2022 Q4 | -24.81 Million CNY | -116.57% |
| 2021 Q2 | 357.9 Million CNY | 17.01% |
| 2021 Q3 | 286.93 Million CNY | -19.83% |
| 2021 Q1 | 305.87 Million CNY | 56.05% |
| 2021 Q4 | 349.53 Million CNY | 21.82% |
| 2021 FY | - CNY | 25.05% |
| 2020 Q4 | 196.01 Million CNY | -15.38% |
| 2020 FY | - CNY | 56.11% |
| 2020 Q3 | 231.64 Million CNY | -47.55% |
| 2020 Q2 | 441.65 Million CNY | 223.61% |
| 2020 Q1 | 136.47 Million CNY | 1560.99% |
| 2019 Q4 | 8.21 Million CNY | -91.18% |
| 2019 FY | - CNY | -6.71% |
| 2019 Q2 | 262.67 Million CNY | 127.89% |
| 2019 Q1 | 115.26 Million CNY | 254.6% |
| 2019 Q3 | 93.15 Million CNY | -64.54% |
| 2018 FY | - CNY | 34.89% |
| 2018 Q1 | 602.16 Million CNY | 216.67% |
| 2018 Q2 | 11.24 Million CNY | -98.13% |
| 2018 Q3 | 69.33 Million CNY | 516.48% |
| 2018 Q4 | -74.55 Million CNY | -207.52% |
| 2017 Q1 | 91.67 Million CNY | -8.1% |
| 2017 FY | - CNY | -28.9% |
| 2017 Q2 | 62.64 Million CNY | -31.66% |
| 2017 Q3 | 38.81 Million CNY | -38.04% |
| 2017 Q4 | 190.15 Million CNY | 389.84% |
| 2016 Q1 | 123.52 Million CNY | -36.54% |
| 2016 Q2 | 190.45 Million CNY | 54.19% |
| 2016 Q3 | 301.88 Million CNY | 58.51% |
| 2016 Q4 | 99.74 Million CNY | -66.96% |
| 2016 FY | - CNY | 68.89% |
| 2015 FY | - CNY | 9.72% |
| 2015 Q4 | 194.64 Million CNY | 465.36% |
| 2015 Q3 | 34.42 Million CNY | -88.18% |
| 2015 Q2 | 291.2 Million CNY | 1561.28% |
| 2015 Q1 | -19.92 Million CNY | 71.43% |
| 2014 FY | - CNY | -26.29% |
| 2014 Q3 | 100.66 Million CNY | -41.9% |
| 2014 Q2 | 173.25 Million CNY | 55.47% |
| 2014 Q1 | 111.44 Million CNY | 221.75% |
| 2014 Q4 | -69.76 Million CNY | -169.3% |
| 2013 Q1 | 239.28 Million CNY | 39.45% |
| 2013 FY | - CNY | -33.74% |
| 2013 Q2 | 258.07 Million CNY | 7.85% |
| 2013 Q4 | 34.63 Million CNY | -62.28% |
| 2013 Q3 | 91.82 Million CNY | -64.42% |
| 2012 Q3 | 206.48 Million CNY | -34.27% |
| 2012 Q4 | 171.59 Million CNY | -16.9% |
| 2012 Q2 | 314.12 Million CNY | -8.46% |
| 2012 Q1 | 343.16 Million CNY | 45.93% |
| 2012 FY | - CNY | -14.17% |
| 2011 Q4 | 235.15 Million CNY | -14.6% |
| 2011 FY | - CNY | -8.43% |
| 2011 Q1 | 329.73 Million CNY | 11.16% |
| 2011 Q2 | 391.79 Million CNY | 18.82% |
| 2011 Q3 | 275.34 Million CNY | -29.72% |
| 2010 Q2 | 376.68 Million CNY | 0.28% |
| 2010 FY | - CNY | -11.09% |
| 2010 Q3 | 336.11 Million CNY | -10.77% |
| 2010 Q4 | 296.62 Million CNY | -11.75% |
| 2010 Q1 | 375.63 Million CNY | -44.14% |
| 2009 FY | - CNY | 15.13% |
| 2009 Q3 | 522.47 Million CNY | 101.61% |
| 2009 Q4 | 672.44 Million CNY | 28.7% |
| 2009 Q1 | 129.3 Million CNY | -56.27% |
| 2009 Q2 | 259.14 Million CNY | 100.42% |
| 2008 Q2 | 494.84 Million CNY | 212.67% |
| 2008 Q1 | 158.26 Million CNY | 22.48% |
| 2008 FY | - CNY | 391.35% |
| 2008 Q4 | 295.67 Million CNY | -28.29% |
| 2008 Q3 | 412.31 Million CNY | -16.68% |
| 2007 FY | - CNY | 17.3% |
| 2007 Q1 | 26.76 Million CNY | -30.41% |
| 2007 Q3 | 21.3 Million CNY | 45.51% |
| 2007 Q2 | 14.64 Million CNY | -45.29% |
| 2007 Q4 | 129.21 Million CNY | 506.44% |
| 2006 Q3 | 70.82 Million CNY | -7.31% |
| 2006 FY | - CNY | 13.17% |
| 2006 Q4 | 38.45 Million CNY | -45.71% |
| 2006 Q1 | 72.32 Million CNY | 41.25% |
| 2006 Q2 | 76.41 Million CNY | 5.66% |
| 2005 FY | - CNY | 74.46% |
| 2005 Q4 | 51.2 Million CNY | -22.8% |
| 2005 Q3 | 66.32 Million CNY | -7.83% |
| 2005 Q1 | 38.19 Million CNY | -1.05% |
| 2005 Q2 | 71.95 Million CNY | 88.42% |
| 2004 Q4 | 38.59 Million CNY | 25.66% |
| 2004 FY | - CNY | 13.51% |
| 2004 Q3 | 30.71 Million CNY | -11.83% |
| 2004 Q2 | 34.83 Million CNY | 17.44% |
| 2004 Q1 | 29.66 Million CNY | -3.6% |
| 2003 Q1 | 31.24 Million CNY | 65.8% |
| 2003 Q2 | 32.06 Million CNY | 2.64% |
| 2003 Q4 | 30.77 Million CNY | 37.1% |
| 2003 FY | - CNY | -5.34% |
| 2003 Q3 | 22.44 Million CNY | -30.01% |
| 2002 Q1 | 21.99 Million CNY | 0.0% |
| 2002 FY | - CNY | 17.99% |
| 2002 Q4 | 18.84 Million CNY | 59.93% |
| 2002 Q3 | 11.78 Million CNY | -55.3% |
| 2002 Q2 | 26.35 Million CNY | 19.86% |
| 2001 FY | - CNY | -11.23% |
| 2000 FY | - CNY | -16.47% |
| 1999 FY | - CNY | 1.2% |
| 1998 FY | - CNY | 53.81% |
| 1997 FY | - CNY | 50.91% |
| 1996 FY | - CNY | 0.0% |